NEW YORK, March 14, 2018 – Hearst announced today that Charles Tuchinda, MD, MBA has been named executive vice president and deputy group head of Hearst Health and a vice president of Hearst, effective immediately. The announcement was made by Steven R. Swartz, president and CEO of Hearst and Gregory Dorn, MD, president and group head of Hearst Health. Tuchinda will continue to serve as president of FDB (First Databank), Hearst’s largest wholly-owned stand-alone business.
In this newly created role, Tuchinda will help provide leadership for the Hearst Health businesses and guidance for Hearst’s acquisition strategy in the healthcare industry. Hearst Health includes the market-leading healthcare companies FDB, Zynx Health, MCG Health, Homecare Homebase and MedHOK, as well as Hearst Health Ventures and the Hearst Health Innovation Lab. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 70 million home health visits and 3.2 billion dispensed prescriptions.
Swartz commented: “Hearst has assembled a unique set of companies that address a great need to support decision making across the healthcare spectrum. Chuck will play a vital role in extending our influence and reach, and I am delighted he will join Greg’s senior leadership team.”
“I have worked closely with Chuck for many years, and he is an exceptionally talented leader and innovator with an outstanding record of success operating businesses,” Dorn said. “Chuck will help me shape Hearst Health’s strategy to ensure our group’s continued growth and positive impact on healthcare.”
In 2014, Tuchinda was named the president of FDB, the leading provider of drug and medical device knowledge. Under his leadership, the company expanded into adjacent markets and delivered double-digit growth. He first joined Hearst in 2010 as the chief innovation officer for healthcare, after holding a variety of executive roles at Eclipsys (now Allscripts), including vice president of business development and product strategy, vice president of acute care solutions and vice president of content solutions.
“I am excited to work with Greg and my talented colleagues across Hearst Health to advance our important mission,” Tuchinda said. “The care guidance we provide has proven to be essential for improving healthcare, and there is still much work to be done.”
A board-certified internal medicine physician, Tuchinda completed both his medical doctorate and residency training at Johns Hopkins. He received a master’s degree in business administration from Harvard Business School and a biomedical engineering degree from Harvard College.
Hearst is one of the nation's largest diversified media, information and services companies with more than 360 businesses. Its major interests include ownership in cable television networks such as A&E, HISTORY, Lifetime and ESPN; majority ownership of global ratings agency Fitch Group; Hearst Health, a group of medical information and services businesses; 30 television stations such as WCVB-TV in Boston and KCRA-TV in Sacramento, Calif., which reach a combined 19 percent of U.S. viewers; newspapers such as the Houston Chronicle, San Francisco Chronicle and Albany Times Union, nearly 300 magazines around the world including Cosmopolitan, ELLE, Harper's BAZAAR and Car and Driver; digital services businesses such as iCrossing and KUBRA; and investments in emerging digital and video companies such as BuzzFeed, Vice, Complex Networks and AwesomenessTV. Follow us on Twitter @HearstLive and @Hearst.
About Hearst Health
The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MedHOK, Hearst Health Ventures and the Hearst Health Innovation Lab (www.hearsthealth.com). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 70 million home health visits and 3.2 billion dispensed prescriptions.